Shiniu Wei, MBA

Mr. Shiniu Wei is a seasoned financial executive with decades of experience in capital markets, corporate finance, and investment strategy.

Prior to joining OncoC4, Mr. Wei most recently held an executive role as the CFO and Vice President of Investor Relations at GenScript Biotech (HK 1548), a global leader in Biotechnology and life science tools & services industry, where he successfully oversaw financial strategy and management across the conglomerate group with over $1 billion in annual revenue. In this role, he also led multiple key initiatives in fundraising across both the Hong Kong and U.S. markets.

Prior to joining GenScript, Shiniu was Executive Director of Secondary Market Investments at Fosun Insurance Group, where he managed diversified equity portfolios across the U.S. and China.

His earlier career includes serving as Senior Analyst and Co-Portfolio Manager at ISF Management, LLC, and as an Analyst at Protocol Capital Management, LLC, focusing on fundamental research and cross-sector equity investments. Shiniu holds an MBA in Finance and Economics from Baruch College, and a B.S. from Nanjing University.